3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Liver Failure
1
Leukemia-Lymphoma, Adult T-Cell
1
Hepatitis C
1
Hepatitis B
1
Hepatic Insufficiency
1
Head and Neck Neoplasms
1
HIV Infections
1
Carcinoma, Hepatocellular
1
Interventions
Doxorubicin
18
Vincristine
15
Zidovudine
11
Bleomycin
11
Cyclophosphamide
9
Etoposide
8
Interferon alpha-2
6
Prednisone
5
Cytarabine
5
tecogalan
4
sargramostim
4
Rituximab
4
Polymerase Chain Reaction
4
Liposomes
4
Filgrastim
4
Dexamethasone
4
Methotrexate
3
Leucovorin
3
Fluorouracil
3
interferon alfa-n1
2
Watchful Waiting
2
Vinblastine
2
Tumor Necrosis Factor-alpha
2
Thalidomide
2
Semaxinib
2
Ritonavir
2
Peripheral Blood Stem Cell Transplantation
2
Mitoxantrone
2
Light Coagulation
2
Isotretinoin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
HIV Infections
×
Raltegravir Potassium
×
Clear all
NCT01022476
2026-04-06
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2
Completed
14 enrolled